We are live on ! Find out more
JAM

JW Asset Management Portfolio holdings

AUM $244M
1-Year Est. Return 71.51%
This Fund
S&P 500
This Quarter Est. Return
-22.02%
1 Year Est. Return
+71.51%
3 Year Est. Return
+125.61%
5 Year Est. Return
+131.61%
10 Year Est. Return
+2,490.27%
AUM
$153M
AUM Growth
-$115M
Cap. Flow
-$44.1M
Cap. Flow %
-28.78%
Top 10 Hldgs %
74.73%
Holding
47
New
4
Increased
2
Reduced
12
Closed
7

Top Buys

Rank Stock Value
1
ARLZ
Aralez Pharmaceuticals Inc.
ARLZ
+$9.47M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$4.34M
3
META icon
Meta Platforms (Facebook)
META
+$1.85M
4
ADVM
Adverum Biotechnologies
ADVM
+$1.06M
5
CMG icon
Chipotle Mexican Grill
CMG
+$951K

Top Sells

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$14.2M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$11.4M
3
CXRX
Concordia International Corp. Common Stock
CXRX
+$8.65M
4
AMZN icon
Amazon
AMZN
+$6.24M
5
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
+$6.17M

Sector Composition

Rank Sector Weight
1 Healthcare 60.96%
2 Consumer Discretionary 14.95%
3 Communication Services 13.93%
4 Financials 5.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STRR
26
DELISTED
Star Equity Holdings
STRR
$547K 0.36%
2,205
– –
ADMS
27
DELISTED
Adamas Pharmaceuticals
ADMS
$436K 0.28%
30,140
– –
AKRX
28
DELISTED
Akorn Inc
AKRX
$388K 0.25%
16,506
– –
SRPT icon
29
Sarepta Therapeutics
SRPT
$1.65B
$351K 0.23%
17,974
+10,000
+125% +$175K
TLGT
30
DELISTED
Teligent, Inc
TLGT
$313K 0.2%
6,382
-2,690
-30% -$168K
XNPT
31
DELISTED
XENOPORT, INC.
XNPT
$226K 0.15%
50,000
– –
FOLD
32
DELISTED
Amicus Therapeutics
FOLD
$169K 0.11%
20,000
– –
ATRS
33
DELISTED
Antares Pharma, Inc.
ATRS
$124K 0.08%
142,198
– –
PJT icon
34
PJT Partners
PJT
$4.28B
$120K 0.08%
5,000
-5,364
-52% -$138K
CCLD icon
35
CareCloud
CCLD
$104M
$65K 0.04%
63,771
– –
CPIX icon
36
Cumberland Pharmaceuticals
CPIX
$98.9M
$49K 0.03%
10,939
– –
VANI icon
37
Vivani Medical
VANI
$111M
$41K 0.03%
354
– –
CTIC
38
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$27K 0.02%
5,025
– –
VXRT
39
DELISTED
Vaxart
VXRT
$13K 0.01%
783
– –
NSPH
40
DELISTED
NANOSPHERE INC. COM NEW
NSPH
$3K ﹤0.01%
3,451
– –
JAZZ icon
41
Jazz Pharmaceuticals
JAZZ
$16.1B
– –
-22,559
Closed -$3.17M
PRGO icon
42
Perrigo
PRGO
$1.43B
– –
-19,243
Closed -$2.78M
REGN icon
43
Regeneron Pharmaceuticals
REGN
$72.9B
– –
-21,080
Closed -$11.4M
RMTI icon
44
Rockwell Medical
RMTI
$27.2M
– –
-38
Closed -$43K
WW
45
DELISTED
WW International
WW
– –
-18,890
Closed -$431K
TARO
46
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
– –
-6,783
Closed -$1.05M
PTX
47
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
– –
-6,701
Closed -$198K
1
2

Similar funds

SC
Schulhoff & Co Cincinnati, Ohio $243M AUM 17.47% 1-Year Est. Return
HCM
Hutner Capital Management Manchester, Vermont $243M AUM 10.01% 1-Year Est. Return
SC
Solstein Capital Menlo Park, California $244M AUM 29.05% 1-Year Est. Return
HBS
Howard Bailey Securities Fort Wayne, Indiana $243M AUM 13.36% 1-Year Est. Return
GIM
GE Investment Management Norwalk, Connecticut $244M AUM 41.62% 1-Year Est. Return
IFO
Independent Family Office Albany, New York $243M AUM 21.81% 1-Year Est. Return
VG
Visualize Group New York $243M AUM 6.21% 1-Year Est. Return
CP
Creekside Partners Petaluma, California $243M AUM 20.23% 1-Year Est. Return

JW Asset Management's Q1 2016 Portfolio in Review

As of Q1 2016, JW Asset Management held 47 positions worth $153M, down 43% from $268M the previous quarter. Its ten largest holdings account for 75% of the portfolio.

JW Asset Management withdrew a net $44.1M in Q1 2016, closing 7 positions and reducing 12 holdings. Its most notable exit was Regeneron Pharmaceuticals, an estimated $11.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 61% of assets, down from 70% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, JW Asset Management opened a new position in Aralez Pharmaceuticals Inc. worth $6.52M.

  • JW Asset Management's largest Q1 2016 buy was Aralez Pharmaceuticals Inc.: 1,836,375 shares worth $6.52M.
  • JW Asset Management added most to Meta Platforms (Facebook) in Q1 2016, an estimated $1.85M increase.
  • JW Asset Management's biggest Q1 2016 reduction was Netflix, cutting an estimated $14.2M.
  • JW Asset Management fully exited Regeneron Pharmaceuticals in Q1 2016, selling an estimated $11.4M.
  • JW Asset Management's ten largest holdings make up 75% of its $153M portfolio in Q1 2016.
  • JW Asset Management opened 4 new positions and closed 7 in Q1 2016.
  • JW Asset Management's portfolio value fell 43% quarter-over-quarter to $153M.

Based on JW Asset Management's 13F filing for Q1 2016, filed 12 May 2016.